Literature DB >> 2865108

The fate of N-methylformamide in mice. Routes of elimination and characterization of metabolites.

P Kestell, A Gescher, J A Slack.   

Abstract

The fate of N-methylformamide has been investigated in male CBA/CA mice following the administration of this compound labeled with 14C either in the methyl or in the formyl group. The major route of elimination was found to be via the kidneys although a substantial quantity (39% of the dose) was eliminated via the lungs as CO2 in the case of [14C]formyl-labeled N-methylformamide. In addition to the unchanged compound three metabolites were found in the urine by TLC autoradiography. One of these metabolites was identified as methylamine after conversion to its 2,4-dinitrophenyl derivative. The derivative was isolated and shown to be N-methyl-2,4-dinitroaniline by mass spectrometry. Further evidence that methylamine was a metabolite of N-methylformamide was provided by ion pair HPLC analysis of urine from mice dosed with [14C]methyl-labeled N-methylformamide. The second metabolite was tentatively identified as N-hydroxymethylformamide which was present in the urine of mice dosed with either [14C]methyl- or [14C]formyl-labeled N-methylformamide. Formate was not a urinary metabolite of N-methylformamide. The identity of the third urinary metabolite remains unknown.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2865108

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  3 in total

1.  Comparative hepatotoxicity and metabolism of N-methylformamide in rats and mice.

Authors:  K Tulip; J A Timbrell
Journal:  Arch Toxicol       Date:  1988       Impact factor: 5.153

Review 2.  N-methyl antitumour agents. A distinct class of anticancer drugs?

Authors:  D Newell; A Gescher; S Harland; D Ross; C Rutty
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

3.  Twenty-seventh annual general meeting of the British Association for Cancer Research (in conjunction with the inaugural meeting of the Association of Cancer Physicians). March 24-26, 1986, Bristol, UK. Abstracts.

Authors: 
Journal:  Br J Cancer       Date:  1986-07       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.